Results 51 to 60 of about 17,241 (100)
, 2012 Vacuna frente a Acinetobacter.La invención se refiere a una composición que comprende células inactivadas del género Acínetobacter y/o proteínas aisladas de las mismas y a su uso para la elaboración de un medicamento, preferiblemente una vacuna, para la
Mcconnell, Michael, Pachón, Jerónimo
core +1 more source
[Inappropriate actions in adult vaccination]. [PDF]
Aten Primaria, 2018 Aldaz Herce P +6 more
europepmc +1 more source
Prevención de las enfermedades infecciosas. Actualización PAPPS en vacunas 2018. [PDF]
Aten Primaria, 2018 Aldaz Herce P +8 more
europepmc +1 more source
[Prevention of infectious diseases. Update on PAPPS 2024 vaccines]. [PDF]
Aten PrimariaJavierre Miranda AP +9 more
europepmc +1 more source
[Infarction and splenic abscess as the cause of acute abdomen in a patient with myelomonocytic leukemia]. [PDF]
Rev Med Inst Mex Seguro SocBeristain-Hernández JL +3 more
europepmc +1 more source
Strategic evaluations and techno-economic networks. Vaccine innovation in the Cuban biotech sector: for public health – or for profits? [PDF]
In this paper the Cuban biotech sector with its highly integrated vaccine industry is analyzed in the perspective of the techno-economic network model of Michel Callon. The paper discusses the strategic evaluations that have been performed in the sector.
Jens Plahte
core
[Prevention of infectious diseases]. [PDF]
Aten Primaria, 2014 Aldaz Herce P +9 more
europepmc +1 more source
Impact and effectiveness of meningococcal vaccines: a review. [PDF]
Rev Panam Salud Publica, 2017 Helena De Oliveira L +3 more
europepmc +1 more source